Your browser doesn't support javascript.
loading
Prenatally diagnosed congenital heart disease: the cost of maternal care.
Einerson, Brett D; Nelson, Richard; Botto, Lorenzo D; Minich, L LuAnn; Krikov, Sergey; Waitzman, Norman; Pinto, Nelangi M.
Afiliação
  • Einerson BD; Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Utah, Salt Lake City, UT, USA.
  • Nelson R; Division of Epidemiology, Department of Internal Medicine, University of Utah, Salt Lake City, UT, USA.
  • Botto LD; Division of Medical Genetics, Department of Pediatrics, University of Utah, Salt Lake City, UT, USA.
  • Minich LL; Division of Pediatric Cardiology, Department of Pediatrics, University of Utah, Salt Lake City, UT, USA.
  • Krikov S; Division of Medical Genetics, Department of Pediatrics, University of Utah, Salt Lake City, UT, USA.
  • Waitzman N; Department of Economics, University of Utah, Salt Lake City, UT, USA.
  • Pinto NM; Division of Pediatric Cardiology, Department of Pediatrics, University of Utah, Salt Lake City, UT, USA.
J Matern Fetal Neonatal Med ; 35(26): 10428-10434, 2022 Dec.
Article em En | MEDLINE | ID: mdl-36191921
OBJECTIVE: Little is known regarding the effects of a prenatal diagnosis of congenital heart disease (CHD) on the cost of antenatal and delivery care. We sought to compare the maternal costs of care in pregnancies where the fetus or child was diagnosed prenatally vs. postnatally. METHODS: Costs of maternal care were determined for pregnancies in which the fetus or child was diagnosed with CHD between 1997 and 2012 in the state of Utah. Cases of CHD were identified via a statewide birth defect surveillance program which included data on the timing of diagnosis, maternal demographic and clinical data, and linked to statewide inpatient maternal hospital discharge records. Antenatal testing costs were determined using Medicaid fee estimates and total facility costs were determined for all hospitalizations including delivery. The association of timing of diagnosis of CHD with costs was analyzed using univariable and multivariable models. RESULTS: Of 2128 pregnancies included in the study, 36% had a fetus prenatally diagnosed with CHD. The prenatal diagnosis group was more likely to have a termination or stillbirth and were younger at delivery (gestational age 37.3 vs 38.0 weeks, p < .001). Labor induction and cesarean delivery rates were similar between groups. Antenatal testing and delivery hospitalization costs were higher in the prenatal diagnosis group: $5819 vs $4041 (p < .001) and $10,509 vs $7802 (p < .001), respectively. Patients in the prenatal diagnosis group had longer lengths of hospital stays (3.5 vs 2.4 d, p > .001). After controlling for significant differences between the groups, including lesion severity, the prenatal diagnosis remained directly associated with antenatal testing costs (+$1472), maternal hospitalization costs (+$2713), and maternal hospital length of stay (+1.0 d). CONCLUSION: A prenatal diagnosis of fetal CHD was associated with increased prenatal costs, hospitalization costs, and hospital length of stay for affected pregnant patients.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Fetais / Cardiopatias Congênitas Tipo de estudo: Diagnostic_studies / Health_economic_evaluation Limite: Adult / Female / Humans / Newborn / Pregnancy Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Fetais / Cardiopatias Congênitas Tipo de estudo: Diagnostic_studies / Health_economic_evaluation Limite: Adult / Female / Humans / Newborn / Pregnancy Idioma: En Ano de publicação: 2022 Tipo de documento: Article